Life Sciences

Finding sustainability in biotechnology, pharmaceutical and medical technology

Amplified business decisions are the new norm thanks to rapid changes. From new market entrants and regulatory reform to expiring patents and the growing challenge of chronic diseases, leaders in the life sciences community must explore a new course to address the changing climate for health care — one driven by patients and focused on health outcomes.

Our Global Life Sciences Center brings together a worldwide team of professionals to help you achieve your potential.

We cover key issues in these areas:

Related content

EY - Order from chaos

Order from chaos

Powerful analytics, combined with maturation of open architecture systems, cloud-computing and predictive analytics are enabling life sciences companies to effectively harness insights in all aspects of their operations.

Connect with us

Stay connected with us through social media, email alerts or webcasts. Or download our EY Insights app for mobile devices.

EY - Deal Outlook 2015 webcast

You're invited – Deal Outlook 2015 webcast

Join us on 11 February for an informative session on current deal drivers, market trends and a 2015 deal outlook for various sectors, including life sciences.

EY - London skyline and River Thames

Supporting fast growth businesses and entrepreneurship in London

London is a global business hub. Find out how we bring our experience of the city and its issues together with specific industry knowledge to support London businesses.

EY Life Sciences: Tax Law video

EY - Global Life Sciences - Tax Law video

EY's Virginie Lefebvre-Dutilleul tells us about how EY's legal credentials can add value to our work with life sciences clients.

Services described in the video cannot be provided by member firms in certain jurisdictions such as the United States.


EY-Applying IFRS 10 and IFRS 11

Applying IFRS 10 and IFRS 11

How will IFRS 10 and IFRS 11 impact collaboration arrangements in the life sciences industry? We explain.